Rising Colorectal Cancer in Young Adults: Implications for Screening
Clinician's RoundtableRising Colorectal Cancer in Young Adults: Implications for Screening
Christopher Cann, MD
Navigating Classification of High-Grade Neuroendocrine Neoplasms
Project Oncology®Navigating Classification of High-Grade Neuroendocrine Neoplasms
Charles Turck, PharmD, BCPS, BCCCP
Rohit Thummalapalli, MD
Advancing Management of Extrapulmonary NEC: The Emerging Role of DLL3
Project Oncology®Advancing Management of Extrapulmonary NEC: The Emerging Role of DLL3
Charles Turck, PharmD, BCPS, BCCCP
Rohit Thummalapalli, MD
Managing Early Esophageal and Gastric Cancers: ASGE Recommendations on ESD and EMR
GI InsightsManaging Early Esophageal and Gastric Cancers: ASGE Recommendations on ESD and EMR
Peter Buch, MD, FACG, AGAF, FACP
Vivek Kaul, MD
Screening Modalities for Colon Cancer: What You Need to Know
GI InsightsScreening Modalities for Colon Cancer: What You Need to Know
Peter Buch, MD, FACG, AGAF, FACP
Aasma Shaukat, MD, MPH
Survival Outcomes in Squamous Cell Carcinoma of the Anal Canal: POD1UM-303 Data
Project Oncology®Survival Outcomes in Squamous Cell Carcinoma of the Anal Canal: POD1UM-303 Data
Brian P. McDonough, MD, FAAFP
Stacey Cohen, MD
- advertisement
IBD Masterclass: Choosing the Right IBD Therapy - A Patient-Clinician Connection
CME/CEIBD Masterclass: Choosing the Right IBD Therapy - A Patient-Clinician Connection
Florence Odufalu, MD
Ugo Iroku, MD, MHS
David T. Rubin, MD
Michael Dolinger, MD, MBA
Florence Odufalu, MD
Ugo Iroku, MD, MHS
Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP
Beyond One-Size-Fits-All: Individualizing First-Line IBD Treatment
MinuteCE®Beyond One-Size-Fits-All: Individualizing First-Line IBD Treatment
Michael Dolinger, MD, MBA
Florence Odufalu, MD
Gut-Selective Therapy: Understanding Anti-Integrins in IBD
MinuteCE®Gut-Selective Therapy: Understanding Anti-Integrins in IBD
Michael Dolinger, MD, MBA
David T. Rubin, MD
Targeting IL-23 Pathways: Evolving Biologic Strategies in IBD
MinuteCE®Targeting IL-23 Pathways: Evolving Biologic Strategies in IBD
Michael Dolinger, MD, MBA
David T. Rubin, MD
The Future of Biologic Treatment in IBD: What’s on the Horizon
MinuteCE®The Future of Biologic Treatment in IBD: What’s on the Horizon
Michael Dolinger, MD, MBA
David T. Rubin, MD
- advertisement
Long-Term Efficacy and Safety Data in Ulcerative Colitis
Medical Industry FeatureLong-Term Efficacy and Safety Data in Ulcerative Colitis
Erica Cohen, MD
Ana’s Story – A Real Patient Living With Ulcerative Colitis
Medical Industry FeatureAna’s Story – A Real Patient Living With Ulcerative Colitis
Ana, A Real Patient Living With Ulcerative Colitis
Lukasz Kwapisz, MD
On the Frontline: Empowering IO Therapies for Patients with HER2-Negative G/GEJC
Project Oncology®On the Frontline: Empowering IO Therapies for Patients with HER2-Negative G/GEJC
Charles Turck, PharmD, BCPS, BCCCP
Jun Gong, MD
Harnessing the Immune Power: A Uniquely Designed PD-1 Inhibitor for Esophageal Cancer
Project Oncology®Harnessing the Immune Power: A Uniquely Designed PD-1 Inhibitor for Esophageal Cancer
Charles Turck, PharmD, BCPS, BCCCP
Jaffer Ajani, MD
Rise in Early-Onset Colon Cancer Being Studied Through Single-Cell Sequencing
Medical Industry FeatureRise in Early-Onset Colon Cancer Being Studied Through Single-Cell Sequencing
Joel Gabre, M.D, MPH
Pioneering a First in Robotic Liver Transplant
Medical Industry FeaturePioneering a First in Robotic Liver Transplant
Juan P. Rocca, M.D., MHA
- 07/13/2026
- 07/13/2026
- 07/10/2026
- 07/10/2026
- 07/10/2026
- 06/30/2026